WEITZMAN DEBORAH
CEO, PSS Segment
WEITZMAN DEBORAH has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, WEITZMAN DEBORAH is listed as CEO, PSS Segment at CARDINAL HEALTH INC. Inside the rolling window, WEITZMAN DEBORAH reported no open-market purchases and 1 open-market sale totaling $1.7M in CAH.
Companies traded
Other insiders at CAH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WEITZMAN DEBORAH made?
WEITZMAN DEBORAH has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does WEITZMAN DEBORAH trade?
WEITZMAN DEBORAH has filed SEC Form 4 disclosures for 1 company, including CAH.
When was WEITZMAN DEBORAH's most recent SEC Form 4 filing?
WEITZMAN DEBORAH's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is WEITZMAN DEBORAH's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, WEITZMAN DEBORAH is listed as CEO, PSS Segment.
What is WEITZMAN DEBORAH's total buy and sell value in the current window?
Inside the rolling retention window, WEITZMAN DEBORAH bought $0 and sold $1.7M based on SEC Form 4 filings.
What was WEITZMAN DEBORAH's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,354 CAH shares on 2026-08-18, worth $1.7M, per SEC Form 4 filings.